Suppr超能文献

冷冻保存的羊膜可改善显微椎间盘切除术后的临床疗效。

Cryopreserved Amniotic Membrane Improves Clinical Outcomes Following Microdiscectomy.

作者信息

Anderson D Greg, Popov Victor, Raines Andrew L, O'Connell Julie

机构信息

*Department of Orthopaedic Surgery and Neurological Surgery, Thomas Jefferson University †Rothman Institute, Philadelphia, PA ‡Amniox Medical Inc., Atlanta, GA.

出版信息

Clin Spine Surg. 2017 Nov;30(9):413-418. doi: 10.1097/BSD.0000000000000544.

Abstract

STUDY DESIGN

Prospective, randomized controlled trial.

OBJECTIVE

To compare pain, physical/mental functional recovery and recurrent herniation for patients following lumbar microdiscectomy with and without the use of a cryopreserved amniotic tissue graft.

SUMMARY OF BACKGROUND DATA

Although microdiscectomy procedures are routinely successful for patients with lumbar radiculopathy due to herniated disc disease, residual low back pain, and recurrent herniation remain unsolved clinical problems.

METHODS

Following Investigated Review Board approval, 80 subjects were randomized in a 1:1 ratio to either receive cryopreserved amniotic (cAM) tissue or no tissue following elective lumbar microdiscectomy surgery. cAM grafts were applied to the annular defect at the conclusion of the procedure. Patients provided preoperative and postoperative clinical assessment data out to 24 months using the Oswestry Disability Index (ODI), Short Form-12 (SF-12) Health Survey, and Visual Analog Pain Scale for back and leg pain. Patients with symptomatic recurrent disc herniation were recorded.

RESULTS

In total, 48 males and 32 females with an average age of 47.2 years were included. Mean ODI scores for subjects treated with cAM graft demonstrated statistically greater improvement at 6 weeks (14.49 vs. 21.82; P=0.05) and 24 months (6.62 vs. 14.40; P=0.02) compared with controls. Similarly, SF-12 Physical Component Scores demonstrated statistically greater gains in the cAM group at both the 6 weeks and 24 months. None of the subjects in the cAM graft group sustained a recurrent herniation at the same surgical level, whereas 3 patients in the control group sustained a recurrent herniation at the same surgical level, with 2 requiring fusion to manage persistent pain.

CONCLUSIONS

The data demonstrate statistically superior clinical outcomes following lumbar microdiscectomy as measured by ODI and SF-12 (physical composite scale) and a lower rate of recurrent herniation with the use of a cAM tissue graft compared with traditional microdiscectomy.

摘要

研究设计

前瞻性随机对照试验。

目的

比较接受和未接受冷冻保存羊膜组织移植的腰椎间盘显微切除术患者的疼痛、身体/心理功能恢复情况以及复发性椎间盘突出情况。

背景数据总结

尽管椎间盘显微切除术对于因椎间盘突出症导致腰椎神经根病的患者通常很成功,但残留的下腰痛和复发性椎间盘突出仍然是未解决的临床问题。

方法

经调查审查委员会批准后,80名受试者按1:1比例随机分组,分别在择期腰椎间盘显微切除术后接受冷冻保存羊膜(cAM)组织或不接受组织。手术结束时将cAM移植物应用于环形缺损处。患者使用Oswestry功能障碍指数(ODI)、简短健康调查问卷12项版(SF-12)以及背部和腿部疼痛视觉模拟疼痛量表提供术前和术后长达24个月的临床评估数据。记录有症状性复发性椎间盘突出的患者。

结果

总共纳入了48名男性和32名女性,平均年龄为47.2岁。与对照组相比,接受cAM移植物治疗的受试者的平均ODI评分在6周(14.49对21.82;P = 0.05)和24个月(6.62对14.40;P = 0.02)时显示出统计学上更大的改善。同样,SF-12身体成分评分在cAM组的6周和24个月时均显示出统计学上更大的提高。cAM移植物组中没有受试者在同一手术节段出现复发性椎间盘突出,而对照组中有3名患者在同一手术节段出现复发性椎间盘突出,其中2名需要进行融合手术来处理持续疼痛。

结论

数据表明,与传统的椎间盘显微切除术相比,使用cAM组织移植物进行腰椎间盘显微切除术后,通过ODI和SF-12(身体综合量表)测量的临床结果在统计学上更优,且复发性椎间盘突出率更低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验